Reports for BAUSCH HEALTH, CANADA INC.

Company Name

BAUSCH HEALTH, CANADA INC.

Totals

Shortage reports

47

Actual shortage: 0 (0%)
Anticipated shortage: 4 (9%)
Avoided shortage: 6 (13%)
Resolved: 37 (79%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

6 (13%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALDARA P 5% CREAM Resolved 2019-08-01 2019-09-10 90558
ROFACT 300MG CAPSULE Anticipated shortage 2019-09-06 2019-09-09 93246
ROFACT 150MG CAPSULE Anticipated shortage 2019-09-06 2019-09-09 93236
CARBOLITH 600MG CAPSULE Resolved 2019-06-27 2019-08-01 87750
ROFACT 300MG CAPSULE Resolved 2018-10-29 2019-08-01 65751
MESTINON 60MG TABLET Resolved 2019-06-21 2019-07-24 87189
VYLOMA 3.75% CREAM Resolved 2018-06-20 2019-07-13 52708
SUBLINOX 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-06-12 2019-07-05 86505
ETIBI 400MG TABLET Anticipated shortage 2019-06-07 2019-06-27 85831
ETIBI 100MG TABLET Anticipated shortage 2019-06-07 2019-06-27 85828
CORTISONE ACETATE 25MG TABLET Resolved 2019-05-08 2019-06-21 83485
ALDARA P 5% CREAM Avoided shortage 2019-03-22 2019-05-08 79306
ALDARA P 5% CREAM Resolved 2018-08-24 2019-03-15 58980
DELATESTRYL 200MG SOLUTION Resolved 2018-11-09 2019-01-11 66583
CESAMET 0.25MG CAPSULE Resolved 2018-09-10 2018-11-28 61161
CESAMET 0.5MG CAPSULE Resolved 2018-08-31 2018-11-28 59693
CESAMET 1MG CAPSULE Resolved 2018-08-31 2018-11-28 59690
NORITATE 1% CREAM Avoided shortage 2018-10-19 2018-11-09 64990
DELATESTRYL 200MG SOLUTION Avoided shortage 2018-09-10 2018-10-05 61170
NORITATE 1% CREAM Resolved 2018-06-29 2018-08-28 53251

Showing 1 to 20 of 47

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports